Pet-MF

Clinical trials for Pet-MF explained in plain language.

Never miss a new study

Get alerted when new Pet-MF trials appear

Sign up with your email to follow new studies for Pet-MF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for myelofibrosis patients: experimental pill targets resistant disease

Disease control Recruiting now

This early-stage study tests an experimental oral drug, AJ1-11095, in about 76 adults with myelofibrosis (a type of bone marrow cancer) whose disease has stopped responding to standard JAK2 inhibitor therapy. The main goals are to check the drug's safety, find the best dose, and …

Matched conditions: PET-MF

Phase 1 • Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company • Aim: Disease control

Last updated Sep 19, 2026 00:00 UTC

Pet-MF

Get alerted when new Pet-MF trials appear

New hope for myelofibrosis patients: experimental pill targets resistant disease